Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Vicebio is a biopharmaceutical company developing next-generation respiratory virus vaccines using the Molecular Clamp technology.
ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.
Alys Pharmaceuticals is a biopharmaceutical company focused on developing immuno-dermatology treatments.
MiroBio is Harnessing the natural control mechanisms of the immune system.
Versanis Bio discovers and develops medicines that address medical conditions prevalent in older adults.
Sydnexis is engaged in the development of a proprietary treatment for pediatric progressive myopia.
Kurome Therapeutics is a preclinical stage company focused on subverting cancer's ability to evade therapy.
Janpix operates as an oncology-focused startup.
Alderaan is a biotechnology company.
Vaderis Therapeutics is a biotechnology company in the clinical stages that specializes in the treatment of uncommon and orphan diseases.
Breakpoint Therapeutics is a company that discover and develop new anti-cancer drugs.
Yukin Therapeutics specializes in the development of new molecules for the treatment of cancer.
Gadeta is a research and development company that develops immunotherapies for cancer.
Critical Pressure is a virtual bio-pharmaceutical company that develops products to treat vascular dysfunction and shock.
Z Factor Limited is a drug discovery company to identify and develop therapeutic agents to treat alpha-1-antitrypsin deficiency
SuperX is a virtual biopharmaceutical company developing products to deliver anticoagulation without bleeding
ApcinteX develops and markets anticoagulant APC pathway to treat haemophilia.
Kymo Therapeutics has a goal to advance Metabrain’s kynurenine metabolism (KMO) inhibitors towards clinical proof of concept.
Capella Bioscience engages in the discovery and development of monoclonal antibodies.
Medicxi has invested in 43 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Medicxi's top investment sectors include Biotechnology, Therapeutics, Health Care, Pharmaceutical, Medical. The firm invests across 13 different industry categories.
Among tracked funding rounds, ProfoundBio received $112.0M in a Series B round. Medicxi's total known invested capital is $3.2B.
Medicxi's average investment size is $90.5M across its portfolio of 43 companies.
Recent Medicxi portfolio additions include Vicebio, ProfoundBio, Alys Pharmaceuticals, MiroBio, Versanis Bio. These companies were founded in 2020 or later.